Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Application for Individual Manufacturing Quota for a Basic Class of Controlled Substance and for Ephedrine, Pseudoephedrine, and Phenylpropanolamine; DEA Form 189, 12982-12983 [2022-04786]

Agencies

• Department of Justice

[Federal Register Volume 87, Number 45 (Tuesday, March 8, 2022)]
[Notices]
[Pages 12982-12983]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-04786]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0006]


Agency Information Collection Activities; Proposed eCollection, 
eComments Requested; Extension Without Change of a Previously Approved 
Collection; Application for Individual Manufacturing Quota for a Basic 
Class of Controlled Substance and for Ephedrine, Pseudoephedrine, and 
Phenylpropanolamine; DEA Form 189

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 60-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Justice, Drug Enforcement Administration 
(DEA), will be submitting the following information collection request 
to the Office of Management and Budget for review and approval in 
accordance with the Paperwork Reduction Act of 1995. This information 
collection is also associated with the proposed rulemaking ``Management 
of Quotas for Controlled Substances and List I Chemicals.'' It is 
likely that the final rule will not be published before this 
information collection expires on June 30, 2022. If the final rule does 
publish prior to the expiration, it will be published as the 30-Day 
Notice.

DATES: Comments are encouraged and will be accepted for 60 days until 
May 9, 2022.

FOR FURTHER INFORMATION CONTACT: If you have comments, especially on 
the estimated public burden or associated response time, suggestions, 
or need a copy of the proposed information collection instrument with 
instructions or additional information, please contact Scott A. Brinks, 
Regulatory Drafting and Policy Support Section (DPW), Diversion Control 
Division, Drug Enforcement Administration; Mailing Address: 8701 
Morrissette Drive, Springfield, Virginia 22152; Telephone: (571) 776-
2265.

SUPPLEMENTARY INFORMATION: Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of 
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

Overview of This Information Collection

    1. Type of Information Collection: Extension of a currently 
approved collection.

[[Page 12983]]

    2. Title of the Form/Collection: Application for Individual 
Manufacturing Quota for a Basic Class of Controlled Substance and for 
Ephedrine, Pseudoephedrine, and Phenylpropanolamine.
    3. The agency form number, if any, and the applicable component of 
the Department sponsoring the collection: DEA Form 189. The applicable 
component within the Department of Justice is the Drug Enforcement 
Administration, Diversion Control Division.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Affected public (Primary): Business or other for-profit.
    Affected public (Other): None.
    Abstract: Pursuant to 21 U.S.C. 826(c) and 21 CFR 1303.22 and 
1315.22, any person who is registered to manufacture any basic class of 
controlled substances listed in Schedule I or II, or the List I 
chemicals ephedrine, pseudoephedrine, or phenylpropanolamine, and who 
desires to manufacture a quantity of such class or such List I 
chemical, must apply on DEA Form 189 for a manufacturing quota for such 
quantity of such class or List I chemical.
    5. An estimate of the total number of respondents and the amount of 
time estimated for an average respondent to respond: The DEA estimates 
33 respondents complete 859 DEA Form 189 applications annually, and 
that each form takes 0.5 hours to complete.
    6. An estimate of the total public burden (in hours) associated 
with the proposed collection: The DEA estimates this collection takes a 
total of 430 annual burden hours.
    If additional information is required, please contact: Melody 
Braswell, Department Clearance Officer, United States Department of 
Justice, Justice Management Division, Policy and Planning Staff, Two 
Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC 
20530.

    Dated: March 2, 2022.
Melody Braswell,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2022-04786 Filed 3-7-22; 8:45 am]
BILLING CODE 4410-09-P